FDA Adverse Event Injury Summary report: N

ENDEAVOR SPRINT RX CORONARY STENT SYSTEM

MDR report key: 2092757 · Received May 10, 2011

Report

Report Number
9612164-2011-00389
Event Type
Injury
Date Received
May 10, 2011
Date of Event
February 2, 2011
Report Date
April 11, 2011
Manufacturer
MEDTRONIC IRELAND
Product Code
NIQ
PMA / PMN Number
P060033
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). EVALUATION: RESULTS: MYOCARDIAL INFARCTION AND OCCLUSION.

Description of Event or Problem · 1

ONE 3.5 X 15 ENDEAVOR SPRINT RX DRUG-ELUTING STENT WAS IMPLANTED AT THE LAD. APPROXIMATELY 13 MONTHS LATER, THE PATIENT WAS ADMITTED TO HOSPITAL WITH CHEST PAIN AND PRESSURE. PATIENT UNDERWENT CT ANGIOGRAM TO RULE OUT PULMONARY EMBOLISM. THE PATIENTS TROPONIN PEAKED AT 0.9 CONFIRMING A MYOCARDIAL INFARCTION. PATIENT HAD NO ACUTE ST CHANGES. DURING THE ANGIOGRAM, THE PATIENT EXHIBITED MILD IN-STENT RESTENOSIS OF THE LAD STUDY STENT, BUT NO SIGNIFICANT CORONARY ARTERY DISEASE. THE PATIENT WAS DISCHARGED 3 DAYS LATER WITH UNSTABLE ANGINA. INVESTIGATOR HAS INDICATED THAT IN-STENT RESTENOSIS WAS POSSIBLY RELATED TO THE DEVICE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDEAVOR SPRINT RX CORONARY STENT SYSTEM NIQ MEDTRONIC IRELAND NA 0000903568

Patients

Seq Age Sex Outcome Treatment
1 UNK Hospitalization